Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Black Hills Corp
BKH
$5.55B
| $27.9M | 0.02% |
511,813
-522,778
| -51% | -$27.4M |
|
502
First Busey Corp
BUSE
$2.56B
| $27.9M | 0.02% |
1,159,907
+212,782
| +22% | +$5M |
|
503
Wells Fargo
WFC
$254B
| $27.8M | 0.02% |
479,726
-89,010
| -16% | -$4.66M |
|
|
ITCI
504
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $27.8M | 0.02% |
401,357
-87,780
| -18% | -$6.03M |
|
505
Sanofi
SNY
$107B
| $27.8M | 0.02% |
571,254
-88,944
| -13% | -$4.34M |
|
506
Phillips Edison & Co
PECO
$5.5B
| $27.2M | 0.01% |
758,406
-2,685
| -0.4% | -$94.9K |
|
|
CLVT.PRA
507
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $27.2M | 0.01% |
905,143
-50,000
| -5% | -$1.7M |
|
508
Gibraltar Industries
ROCK
$1.28B
| $27.1M | 0.01% |
336,989
-61,194
| -15% | -$4.88M |
|
509
Boot Barn
BOOT
$4.58B
| $27.1M | 0.01% |
285,174
+263,444
| +1,212% | +$21.8M |
|
510
Vertex
VERX
$2.16B
| $27M | 0.01% |
849,154
-10,113
| -1% | -$273K |
|
511
Rhythm Pharmaceuticals
RYTM
$7.31B
| $26.9M | 0.01% |
621,427
-465
| -0.1% | -$20.4K |
|
512
Alnylam Pharmaceuticals
ALNY
$38.3B
| $26.7M | 0.01% |
178,954
-99,127
| -36% | -$16.5M |
|
513
Tower Semiconductor
TSEM
$21.2B
| $26.4M | 0.01% |
789,142
+201,944
| +34% | +$6.28M |
|
|
AMED
514
DELISTED
Amedisys
AMED
| $26.3M | 0.01% |
285,768
-83,985
| -23% | -$7.87M |
|
515
Simply Good Foods
SMPL
$907M
| $26.3M | 0.01% |
772,742
-415,659
| -35% | -$15.3M |
|
516
GE Aerospace
GE
$364B
| $26.3M | 0.01% |
187,661
+52,370
| +39% | +$6.17M |
|
517
Nextpower Inc
NXT
$14.1B
| $26.2M | 0.01% |
465,591
+371,564
| +395% | +$19.8M |
|
|
HCP
518
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $26.1M | 0.01% |
969,409
-638
| -0.1% | -$15.5K |
|
519
Caterpillar
CAT
$361B
| $25.9M | 0.01% |
70,620
-1,693
| -2% | -$541K |
|
520
Atlanta Braves Holdings Series B
BATRK
$3.28B
| $25.9M | 0.01% |
661,845
+21,053
| +3% | +$828K |
|
|
AMK
521
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $25.7M | 0.01% |
726,449
-8,572
| -1% | -$280K |
|
522
WisdomTree
WT
$2.79B
| $25.6M | 0.01% |
2,788,746
+194,369
| +7% | +$1.49M |
|
523
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.66B
| $25.6M | 0.01% |
531,605
+33,185
| +7% | +$1.59M |
|
|
NSA
524
DELISTED
National Storage Affiliates Trust
NSA
| $25.4M | 0.01% |
647,717
-4,455
| -0.7% | -$167K |
|
525
Consensus Cloud Solutions
CCSI
$675M
| $25.2M | 0.01% |
1,587,963
+15,871
| +1% | +$284K |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.